Apimeds Pharmaceuticals US, Inc.
Apimeds Pharmaceuticals US, Inc. provides digital asset treasury solutions in bitcoin treasury infrastructure. The company is based in Ras al-Khaimah, the United Arab Emirates. Apimeds Pharmaceuticals US, Inc. operates as a subsidiary of Inscobee., Inc.
Apimeds Pharmaceuticals US, Inc. (APUS) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: -0.212x
Based on the latest financial reports, Apimeds Pharmaceuticals US, Inc. (APUS) has a cash flow conversion efficiency ratio of -0.212x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-1.73 Million) by net assets ($8.16 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Apimeds Pharmaceuticals US, Inc. - Cash Flow Conversion Efficiency Trend (2021–2024)
This chart illustrates how Apimeds Pharmaceuticals US, Inc.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Apimeds Pharmaceuticals US, Inc. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Apimeds Pharmaceuticals US, Inc. ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
In-Touch Survey Systems Ltd.
V:INX
|
0.004x |
|
Toyo Ventures Holdings Bhd
KLSE:7173
|
0.099x |
|
Moara Cibin SA
RO:MOIB
|
N/A |
|
Antler Gold Inc
V:ANTL
|
0.002x |
|
TomaGold Corporation
PINK:TOGOF
|
1.375x |
|
WISDOM ED.INTL.HLD.HD-01
F:5Q4
|
N/A |
|
Energy Development Company Limited
NSE:ENERGYDEV
|
1.536x |
|
KYM Holdings Bhd
KLSE:8362
|
0.075x |
Annual Cash Flow Conversion Efficiency for Apimeds Pharmaceuticals US, Inc. (2021–2024)
The table below shows the annual cash flow conversion efficiency of Apimeds Pharmaceuticals US, Inc. from 2021 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $-1.36 Million | $-733.53K | 0.540x | +102.74% |
| 2023-12-31 | $31.87K | $-627.79K | -19.698x | -3236.44% |
| 2022-12-31 | $-713.61K | $-448.17K | 0.628x | -81.80% |
| 2021-12-31 | $-238.48K | $-823.11K | 3.451x | -- |